Office of Human Subject Research Protection Program (OHSRPP)

CHRISTUS Institutional Review Board

The CHRISTUS Health Institutional Review Board (IRB) protects the rights and welfare of subjects participating in research. Under FDA regulations, an IRB is an appropriately constituted group that has been formally designated to review and monitor biomedical research involving human subjects. In accordance with FDA regulations, an IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. The involvement of human subjects in research is not permitted until the IRB has approved the research protocol. The CHRISTUS Health IRB abides by the CHRISTUS Health policies and procedures, Catholic Church Directives, Belmont Report, Food, and Drug Administration, and the Office of Human Research Protections federal regulations.

Our Services

• Initial Protocol and Informed Consent form Review
• Annual Continuing Review of Protocol and Informed Consent
• Protocol and Informed Consent form Amendment Review
• Exempt and Expedited Research Review
• Quality Improvement (QI) and Quality Assurance (QA) Review

Our Meeting Times

CHRISTUS Health IRB will convene for a monthly meeting on the third Thursday of each month from 8 a.m. - 10 a.m. Research submissions are due two weeks prior to the meeting.

Contact Us 

For assistance, the Office of Human Subjects Research Protection staff are available Monday – Friday from 8:00 am until 5:00 pm CST. Please feel free to also get in contact with our director, Phyllis Everage.